Lidocaine Infusion for Pancreatic Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking certain heart medications like quinidine, flecainide, disopyramide, or procainamide, or if you have been treated with amiodarone in the past.
What data supports the effectiveness of the drug lidocaine for pancreatic cancer?
Is lidocaine safe for use in humans?
How is the drug lidocaine used in treating pancreatic cancer different from other treatments?
What is the purpose of this trial?
This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients undergoing robotic pancreatectomy for all types of pancreatic cancer.A prospective randomized controlled double blinded trial design will be used for the proposed study.
Research Team
Gina E. Votta-Velis, MD PhD
Principal Investigator
Associate Professor
Eligibility Criteria
This trial is for patients with pancreatic cancer that was initially thought to be removable but found to have spread at surgery. They may have had previous treatments like chemo. Participants must understand and sign a consent form, and their cancer should be measurable by certain medical criteria.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 24-hour lidocaine infusion or a saline infusion during the perioperative period
Follow-up
Participants are monitored for safety and effectiveness after treatment, with blood samples collected perioperatively
Treatment Details
Interventions
- Lidocaine Hydrochloride
Lidocaine Hydrochloride is already approved in European Union, United States, Canada, Japan for the following indications:
- Local anesthesia
- Regional anesthesia
- Heart arrhythmia
- Post-herpetic neuralgia
- Local anesthesia
- Regional anesthesia
- Heart arrhythmia
- Post-herpetic neuralgia
- Skin graft donor site pain
- Local anesthesia
- Regional anesthesia
- Heart arrhythmia
- Local anesthesia
- Regional anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor